Evidence map›Paper›PMID 39976812›Full record

SynthesisNeuropsychology review2026

A Systematic Review of Cognitive and Behavioural Symptoms in CTNNB1 Syndrome.

Mercè Pallarès-Sastre, Imanol Amayra, Monika Salgueiro, Elena Villanueva-Viar, Amaia Lasa-Aranzasti, Maitane García

Abstract readSystematic Review
In one paragraph

Synthesis in Neuropsychology review, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Mercè Pallarès-SastreNeuro-E-Motion Research Team, Department of Psychology, Faculty of Health Sciences, University of Deusto, Avenida de Las Universidades 24, 48007, Bilbao, Spain. m.pallares@deusto.es.ORCID http://orcid.org/0009-0000-2386-3595
Imanol AmayraNeuro-E-Motion Research Team, Department of Psychology, Faculty of Health Sciences, University of Deusto, Avenida de Las Universidades 24, 48007, Bilbao, Spain.ORCID http://orcid.org/0000-0002-3250-628X
Monika SalgueiroDepartment of Clinical and Health Psychology and Research Methodology, Faculty of Psychology, University of the Basque Country UPV/EHU, Donostia, Spain.ORCID http://orcid.org/0000-0002-2150-1221
Elena Villanueva-ViarNeuro-E-Motion Research Team, Department of Psychology, Faculty of Health Sciences, University of Deusto, Avenida de Las Universidades 24, 48007, Bilbao, Spain.ORCID http://orcid.org/0009-0006-8236-5063
Amaia Lasa-AranzastiDepartment of Clinical and Molecular Genetics, Vall d'Hebron University Hospital, Barcelona, Spain.ORCID http://orcid.org/0000-0002-9136-5106
Maitane GarcíaNeuro-E-Motion Research Team, Department of Psychology, Faculty of Health Sciences, University of Deusto, Avenida de Las Universidades 24, 48007, Bilbao, Spain.ORCID http://orcid.org/0000-0003-0895-1751

Funding

Ministerio de Universidades FPU22/00391
6 · The paper itself

Abstract

CTNNB1 syndrome is a rare neurodevelopmental disorder caused by a likely pathogenic or pathogenic variant in the CTNNB1 gene. A systematic review was conducted to examine previous research that provided CTNNB1 syndrome patients, specifically those that described intellectual quotient, motor development, language impairments, behavioural problems and features of autism. Databases examined were PubMed and Scopus. The inclusion criteria were (a) reported human patients diagnosed with CTNNB1 syndrome by a genetic test; (b) were related to cognition, intelligence quotient, motor development, language impairment, behavioural problems or features of autism; (c) did not have another genetic diagnosis and (d) were written in Spanish or English. A total of 42 studies were included. Overall, the symptomatology described was very heterogeneous with varying degrees of impairment among patients. However, individuals reached most significant developmental milestones later than expected and with different degrees of impairment. The use of standardised methodology to assess cognitive and behavioural domains was scarce in most studies, and the vast majority did not include a specific assessment protocol based on the symptomatology of CTNNB1 syndrome individuals. In addition, only two adult patients were described in depth, which implies that there are many unknowns about the progression of the syndrome later in life. Therefore, future research should focus on increasing the sample assessed and count with a standardised protocol in order to characterise the cognitive and behavioural phenotype of CTNNB1 syndrome.

Indexed as

beta CateninCognition DisordersHumansbeta CateninCTNNB1 protein, humanCTNNB1 syndromeFeatures of autismIntellectual disabilityLanguage impairmentsNeurodevelopmental disorder

Identifiers

PMID39976812
PMCPMC13279489

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.